-
EMD Serono Presents Results on Efficacy and Safety of Enpatoran in Systemic Lupus Erythematosus (SLE) at EULAR 2025
12 Jun 2025 12:50 GMT
… unmet needs in lupus treatment.
About Lupus Erythematosus
Lupus …
About EMD Serono, Inc.
EMD Serono - the healthcare business of … with serious unmet medical needs. EMD Serono’s global roots … and services that accelerate drug development and manufacturing as …
-
Simtra BioPharma Solutions and MilliporeSigma Announce Strategic Alliance for Antibody Drug Conjugates Drug Substance and Drug Product Manufacturing Services
11 Jun 2025 12:15 GMT
… ADCs as a cancer treatment option. However, most … ; strategic objectives.
Biotech and pharmaceutical companies partner with us … life science, EMD Serono in healthcare and EMD Electronics … for-antibody-drug-conjugates-drug-substance-and-drug-product-manufacturing …
-
China's Center For Drug Evaluation Accepts Merck's Application For Marketing Authorization Of Pimicotinib For Treatment...
10 Jun 2025 08:56 GMT
… the US Food and Drug Administration, with additional filings … China National Medical Products Administration (NMPA) for the treatment of … -year global heritage as pharma pioneers, we are focusing … in life science, EMD Serono in healthcare, and EMD Electronics …
-
China’s Center for Drug Evaluation Accepts Merck KGaA, Darmstadt, Germany’s Application for Marketing Authorization of Pimicotinib for Treatment of Tenosynovial Giant Cell Tumor
10 Jun 2025 04:13 GMT
… the US Food and Drug Administration, with additional filings … China National Medical Products Administration (NMPA) for the treatment of … -year global heritage as pharma pioneers, we are focusing … life science, EMD Serono in healthcare and EMD Electronics in …
-
Combination treatment extends progression-free survival in advanced skin cancer
01 Jun 2025 16:02 GMT
… trial, associate professor of medicine at the University of … Pittsburgh and medical oncology co-leader of … prognosis is poor and treatment is focused on extending … funding support and drug supply (avelumab) from EMD Serono.
Source:
Journal …
-
Survey Results Point to High Rates of Burnout Among APPs and Pharmacists in Neurology
29 May 2025 17:07 GMT
… providers (APPs) and clinical pharmacists (CPs) in the United … in North America Medical Affairs at EMD Serono, APPs made … at supporting these neurology health care professionals.
Click here … Nurse Practitioners) and Clinical Pharmacists in the United States. …
-
CORRECTING and REPLACING Flatiron Health Announces Research to Be Presented at ASCO 2025
22 May 2025 23:31 GMT
… University of Texas Southwestern Medical Center, University of … Real-world surgical and treatment patterns after neoadjuvant checkpoint … Clinic, Merck KGaA, EMD Serono
Amanda Nizam, Mairead Kearney … Flatiron
Flatiron Health is a healthtech company expanding …
-
EMD Serono Showcases Innovation in Advanced Cancers and Rare Tumors at ASCO 2025
22 May 2025 21:54 GMT
… of its lead antibody-drug conjugate (ADC), precemtabart … year global heritage as pharma pioneers, we are … adrenal insufficiency, initiate symptomatic treatment, including hormone replacement, … Medication Guide.
About EMD Serono, Inc.
EMD Serono - the healthcare …
-
Metastatic Merkel Cell Carcinoma Pipeline Appears Robust With 13+ Key Pharma Companies Actively Working In The Therapeutics Segment | Delveinsight
22 May 2025 04:37 GMT
… Pharmaceuticals Inc., Novartis Pharmaceuticals, Exelixis, Philogen SpA, Bristol-Myers Squibb, EMD Serono … Treatment Drugs
Metastatic Merkel Cell Carcinoma Companies
Incyte Corporation, Merck, Pfizer, Millennium Pharmaceuticals … Biotech
Drug profiles … healthcare …
-
Peritoneal Cancer Pipeline Appears Robust With 55+ Key Pharma Companies Actively Working In The Therapeutics Segment | Delveinsight
21 May 2025 02:35 GMT
… Pharmaceutical, Oncoinvent, ImmunoGen, Arsenal Biosciences, EMD Serono Research & Development Institute, Medicenna … Peritoneal Cancer Treatment Drugs
Peritoneal Cancer Emerging Drugs Profile
Masitinib is … is a leading healthcare-focused market research …